The hospital oversees treatment of about 80 cancer patients and is anticipating a shortage of cancer drugs — including carboplatin and cisplatin, which are used to treat tumors — to persist for several months. The hospital’s cancer center recently requested 800 milligrams of cisplatin from regional vendors, though that is expected to last for only a week.
“We’ve developed a number of mitigation strategies to minimize that impact and risk to each of these very vulnerable patients,” Tod Morris, MD, an oncology specialist at Tallahassee Memorial, told the news station. “We’re going to do everything we can to provide the highest quality outcomes in this difficult situation.”
Across the U.S., near record drug shortages are causing treatment delays for thousands of patients with cancer and other diseases, according to The New York Times.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
